Viewing Study NCT01242267


Ignite Creation Date: 2025-12-25 @ 12:46 AM
Ignite Modification Date: 2026-04-09 @ 6:56 AM
Study NCT ID: NCT01242267
Status: COMPLETED
Last Update Posted: 2023-01-03
First Post: 2010-11-15
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Escalating Doses of Thalidomide in Conjunction With Bortezomib and HIgh Dose Melphalan for BSCT
Sponsor: Hackensack Meridian Health
Organization: